Binkui Li

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0003-3201-2914

发表论文 182 篇 · 总被引 4139 次 · h-index 35

代表论文

• AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation (2024 · Signal Transduction and Targeted Therapy · 被引 21)
• Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study (2024 · International Immunopharmacology · 被引 20)
• USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma (2025 · Proceedings of the National Academy of Sciences · 被引 9)
• Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial (2024 · 癌症：英文版 · 被引 8)
• Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective (2025 · Journal of Hepatocellular Carcinoma · 被引 7)
• Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial (2024 · European Journal of Cancer · 被引 6)